Summary
The product Masteron P 100, manufactured by Unique Pharma, was independently tested to verify its authenticity and potency. The sample, identified by batch number GH65721K, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Drostanolone Propionate with a concentration of 109.27 mg/ml, exceeding the labeled claim of 100 mg/ml by 9.27%.
The testing process commenced on 26 September 2022, with the sample received on 1 October 2022, and the analysis completed on 14 October 2022. While the results confirm accurate dosing with minor variance, it is essential to note that reseller-submitted samples might represent higher-quality batches that do not necessarily reflect overall market consistency. Independent third-party testing remains crucial for comprehensive validation. This report is provided for educational purposes to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: Masteron P 100
- Active Ingredient: Drostanolone Propionate
- Batch Number: GH65721K
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #24386
- Testing Ordered: 26 September 2022
- Sample Received: 1 October 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 100 mg/ml (as stated on the label)
- Measured Concentration: 109.27 mg/ml
- Accuracy: 109.27% (9.27% above the label claim)
- Variance: +9.27%
Verification Details
- Verification URL: www.janoshik.com/tests/24386_2JF979A8SIHT
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This analysis confirms the product’s quality but necessitates careful consideration due to its submission and funding by the reseller Opitropin.EU. Resellers often select optimal batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its rigorous testing protocols, further independent testing across multiple batches is recommended for a comprehensive quality assessment.
Conclusion
The analysis of Masteron P 100 confirms a measured concentration of 109.27 mg/ml, indicating an overdose of 9.27% above the label claim. While this suggests good quality control for this batch, it emphasizes the necessity of additional testing to ensure consistent dosing across production batches. This report aims to support educational and harm reduction efforts, enabling consumers to make informed choices.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may introduce inherent biases; however, it still provides useful insights when critically assessed alongside independent third-party results. Readers are encouraged to use this information responsibly.
